GLR
VRTX icon

Great Lakes Retirement’s Vertex Pharmaceuticals VRTX Stock Holding History

Great Lakes Retirement’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
2,136
+111
+5% +$49.2K 0.09% 159
2026
Q1 		$904K Buy
2,025
+116
+6% +$54.1K 0.09% 161
2025
Q4 		$865K Buy
1,909
+120
+7% +$51.7K 0.09% 163
2025
Q3 		$701K Buy
1,789
+65
+4% +$27.2K 0.08% 162
2025
Q2 		$768K Sell
1,724
-5
-0.3% -$2.3K 0.09% 156
2025
Q1 		$838K Buy
+1,729
New +$806K 0.11% 153
2024
Q3 		– Sell
-88
Closed -$41.2K – 656
2024
Q2 		$41.2K Buy
+88
New +$38.2K 0.01% 301

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Great Lakes Retirement's VRTX Position: Q2 2026 in Review

Great Lakes Retirement increased its Vertex Pharmaceuticals (VRTX) stake by 5.5% in Q2 2026, buying an estimated $49.2K and bringing the position to 2,136 shares worth $1.06M. The position accounts for 0.09% of the portfolio, ranked #159.

Great Lakes Retirement first reported a position in VRTX in Q2 2024 and has held it in 7 quarters since. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Great Lakes Retirement held 2,136 shares of Vertex Pharmaceuticals worth $1.06M as of Q2 2026.
  • Great Lakes Retirement bought 111 Vertex Pharmaceuticals shares in Q2 2026, an estimated $49.2K.
  • Vertex Pharmaceuticals made up 0.09% of Great Lakes Retirement's portfolio in Q2 2026, its #159 holding.
  • Great Lakes Retirement first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Great Lakes Retirement's 13F filing for Q2 2026, filed 30 Jul 2026.